1. FDA response to Citizen Petition Docket No. FDA-2003-P-0273.
2. EMEA. Guidelines on clinical and non-clinical development of medicinal products containing low-molecular-weight heparins. European Medical Agency. London, 19 March 2009. (EMEA/CHMP/BMWP/11826407enfin.pdf). Accessed September 7, 2010.
3. Recommendations on biosimilar low-molecular-weight heparins;Harenberg;J Thromb Haemost,2009
4. A consensus conference on complex biologies and low molecular weight heparin;Kalodiki;Int Angiol,2010
5. SASAT (South Asian Society on Atherosclerosis and Thrombosis) proposal for regulatory guidelines for generic low molecular weight heparins (LMWHs);Kalodiki;Clin Appl Thromb Hemost,2009